OA10583A - Microgranules de dérivés de 5-nitro imidazole - Google Patents

Microgranules de dérivés de 5-nitro imidazole Download PDF

Info

Publication number
OA10583A
OA10583A OA60863A OA60863A OA10583A OA 10583 A OA10583 A OA 10583A OA 60863 A OA60863 A OA 60863A OA 60863 A OA60863 A OA 60863A OA 10583 A OA10583 A OA 10583A
Authority
OA
OAPI
Prior art keywords
microgranules
form according
gastro
release
resistant
Prior art date
Application number
OA60863A
Other languages
English (en)
French (fr)
Inventor
Gerard Leduc
Patrice Debregeas
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of OA10583A publication Critical patent/OA10583A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA60863A 1994-01-14 1996-07-12 Microgranules de dérivés de 5-nitro imidazole OA10583A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.

Publications (1)

Publication Number Publication Date
OA10583A true OA10583A (en) 2002-07-10

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60863A OA10583A (en) 1994-01-14 1996-07-12 Microgranules de dérivés de 5-nitro imidazole

Country Status (19)

Country Link
JP (1) JPH09507499A (da)
KR (1) KR100320140B1 (da)
CN (1) CN1088357C (da)
AT (1) ATE187068T1 (da)
AU (1) AU705570B2 (da)
BR (1) BR9506507A (da)
CZ (1) CZ286080B6 (da)
DE (1) DE69513632T2 (da)
DK (1) DK0739201T3 (da)
ES (1) ES2139883T3 (da)
MA (1) MA23429A1 (da)
MX (1) MX9602772A (da)
NZ (1) NZ279238A (da)
OA (1) OA10583A (da)
PL (1) PL178424B1 (da)
PT (1) PT739201E (da)
RU (1) RU2152212C1 (da)
SK (1) SK282066B6 (da)
UA (1) UA28031C2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
AU7909691A (en) * 1990-05-14 1991-12-10 Gary R. Jernberg Surgical implant and method incorporating chemotherapeutic agents

Also Published As

Publication number Publication date
BR9506507A (pt) 1997-09-09
DE69513632D1 (de) 2000-01-05
PL315530A1 (en) 1996-11-12
AU705570B2 (en) 1999-05-27
MX9602772A (es) 1997-05-31
CZ286080B6 (cs) 2000-01-12
SK91496A3 (en) 1996-12-04
CN1088357C (zh) 2002-07-31
CN1138826A (zh) 1996-12-25
NZ279238A (en) 1998-03-25
AU1580395A (en) 1995-08-01
PL178424B1 (pl) 2000-04-28
UA28031C2 (uk) 2000-10-16
DK0739201T3 (da) 2000-05-01
MA23429A1 (fr) 1995-10-01
DE69513632T2 (de) 2000-04-06
ES2139883T3 (es) 2000-02-16
KR100320140B1 (ko) 2002-07-02
SK282066B6 (sk) 2001-10-08
ATE187068T1 (de) 1999-12-15
JPH09507499A (ja) 1997-07-29
CZ205596A3 (en) 1996-10-16
RU2152212C1 (ru) 2000-07-10
PT739201E (pt) 2000-05-31

Similar Documents

Publication Publication Date Title
BE1014328A7 (fr) Composition pharmaceutique orale a liberation controlee.
BE1015217A5 (da)
CA2231342C (fr) Composition pharmaceutique pour administration par voie orale
FR2629716A1 (fr) Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
BRPI0608853B1 (pt) composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
BR112012021275B1 (pt) Formulação compreendendo um adsorvente misturado com carragenina, para entrega oral e liberação controlada de adsorventes no intestino, e, uso de uma formulação
RU2671400C2 (ru) Фармацевтические композиции для лечения от helicobacter pylori
EP0673650B1 (fr) Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine
JP2018521137A (ja) 液体剤形中の薬学的活性化合物放出性多層微小粒子
FR2762213A1 (fr) Composition pharmaceutique a retention gastrique
BE1015413A6 (fr) Systeme de delivrance orale controlee d'un medicament.
EP0739201B1 (fr) Microgranules de derives de 5-nitro imidazole
US5549911A (en) Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
OA10583A (en) Microgranules de dérivés de 5-nitro imidazole
EP1465607A1 (fr) Compositions pharmaceutiques a liberation modifiee
US20220378758A1 (en) Rifaximin liquid formulations
WO2011100668A1 (en) Methods and compositions of civamide to treat diseases of the intestines
US20230398102A1 (en) Rifaximin liquid formulations for use inthe treatment of sickle cell disease
LU87777A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite
FR2790388A1 (fr) Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
LU86290A1 (fr) Compositions pharmaceutiques a base de 3-aminopropoxyindoles
Kumar Design/Development and Evaluation of Buccal Patches of an Antihypertensive Drug
BE1024339A1 (fr) Microparticules multicouches libérant un composé pharmaceutiquement actif dans une forme pharmaceutique liquide